Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
OBJECTIVE
The metabolism and synthesis of intratumoral estrogens are thought to play a very important role in the etiology and progression of endometrial carcinoma. Aromatase is a key enzyme in the conversion of androgens to estrogens, and aromatase localization studies have reported that aromatase immunoreactivity and mRNA were detected mainly in stromal cells. However, the effect of tumor-stromal interactions on local estrogen biosynthesis in endometrial carcinomas remains largely unknown.


METHODS
The endometrial carcinoma cell lines (Ishikawa and RL95-2) and breast carcinoma cell line (MCF-7) were cocultured with stromal cells isolated from endometrial carcinomas, and aromatization activity was measured using liquid chromatography-tandem mass spectrometry. We then confirmed the local biosynthesis of estrogens and tumor-stromal interactions on aromatase activity in Ishikawa and RL95-2 cells. In addition, we also examined the effects of aromatase inhibitors on cell proliferation.


RESULTS
Aromatase activity was significantly higher in cocultures with Ishikawa or RL95-2 than in each monoculture, respectively. Estrone (E(1)) concentrations were significantly higher than estradiol (E(2)) concentrations in Ishikawa and RL95-2 cells, whereas E(2) was significantly higher than E(1) in MCF-7 cells. Cell proliferation was significantly inhibited in Ishikawa and RL95-2 cell cultures treated with aromatase inhibitors compared with control cultures.


CONCLUSIONS
These results indicate the contribution of not only E(2) but also E(1) to cancer cell proliferation in endometrial carcinoma. Our study may provide important information on metabolism and synthesis of intratumoral estrogens with regard to the etiology and progression of endometrial carcinoma, thus helping to achieve improved clinical responses in patients with endometrial carcinoma, who are treated with aromatase inhibitors.
Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan. naomit@theia.ocn.ne.jp
Naomi
N
Takahashi-Shiga
Hiroki
H
Utsunomiya
Yasuhiro
Y
Miki
Satoru
S
Nagase
Rika
R
Kobayashi
Mitsuyo
M
Matsumoto
Hitoshi
H
Niikura
Kiyoshi
K
Ito
Nobuo
N
Yaegashi
D015067:17-Hydroxysteroid Dehydrogenases / Q000235:genetics; D041721:3T3-L1 Cells; D000818:Animals; D001141:Aromatase / Q000235:genetics; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism*; D002450:Cell Communication / Q000187:drug effects / Q000502:physiology*; D049109:Cell Proliferation / Q000187:drug effects; D016889:Endometrial Neoplasms / Q000235:genetics / Q000378:metabolism*; D004960:Estradiol Dehydrogenases / Q000235:genetics; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism; D004967:Estrogens / Q000096:biosynthesis* / Q000494:pharmacology; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051379:Mice; D017154:Stromal Cells / Q000378:metabolism / Q000502:physiology*; D014018:Tissue Distribution; D014407:Tumor Cells, Cultured
D047628:Estrogen Receptor alpha; D004967:Estrogens; D015067:17-Hydroxysteroid Dehydrogenases; C044256:3 (or 17)-beta-hydroxysteroid dehydrogenase; D004960:Estradiol Dehydrogenases; C523763:HSD17B2 protein, human; D001141:Aromatase